Sort
39,280 grants matching “leukemia”
SOUTHWEST ONCOLOGY GROUP
$319,468Wayne State University · U10 · FY2001 · CA
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
$319,457Chung S Yang · Rutgers, The State Univ Of N.J. · R01 · FY2009 · CA
Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin
$319,457Chung S Yang · Rutgers, The State Univ Of N.J. · R01 · FY2010 · CA
Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer
$319,441Jane Amanda Skok · New York University School Of Medicine · P01 · FY2022 · CA
A novel cilium-to-nucleus axis promotes cellular senescence
$319,431Jinghua Hu · Mayo Clinic Rochester · R01 · FY2025 · AG
Pathology
$319,401Sherif S Farag · Ohio State University · P01 · FY2007 · CA
Interactions of Retroviral Proteins with Nucleic Acids
$319,375Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Role of AML1-ETO in Acute Leukemia
$319,365Vanderbilt University · R01 · FY2005 · CA
Role of AML1-ETO in Acute Leukemia
$319,365Vanderbilt University · R01 · FY2004 · CA
Role of AML1-ETO in Acute Leukemia
$319,365Vanderbilt University · R01 · FY2003 · CA
Hypoxia-induced Metabolic Changes in Cancer
$319,362Othon Iliopoulos · Massachusetts General Hospital · R01 · FY2016 · CA
Hypoxia-induced Metabolic Changes in Cancer
$319,362Othon Iliopoulos · Massachusetts General Hospital · R01 · FY2015 · CA
The Role of Physical Cues in Collective Cell Invasion
$319,334Konstantinos Konstantopoulos · Johns Hopkins University · U54 · FY2017 · CA
Optimizing decitabine regimen + formulation for nonDNA damaging DNMT1 depletion
$319,326Yogen Saunthararajah · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
Optimizing decitabine regimen + formulation for nonDNA damaging DNMT1 depletion
$319,326Yogen Saunthararajah · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
Roles of Lig3 and XRCC1 Genes in Genome Stability
$319,311Alan E Tomkinson · University Of New Mexico Health Scis Ctr · R01 · FY2016 · ES
MICRODETECTION ASSAY FOR DRUG RESISTANT TUMORS
$319,302University Of Illinois At Chicago · R01 · FY2001 · CA
Characterizing the landscape of resistance and persistence mechanisms in CML
$319,299Brian J Druker · Oregon Health & Science University · R01 · FY2019 · CA
North American Juvenile Myelomonocytic Leukemia Project
$319,297University Of Alabama At Birmingham · R01 · FY2005 · CA
Computational Structure-Based Protein Design
$319,289Bruce R. Donald · Duke University · R01 · FY2014 · GM
Functional analysis of vertebrate nuclear transport
$319,224Maureen A. Powers · Emory University · R01 · FY2006 · GM
Project 1: Immunotherapy of B cell lymphoma with NKT cells
$319,192Leonid S Metelitsa · Baylor College Of Medicine · P50 · FY2022 · CA
Prevention and Treatment of Graft-Versus-Host Disease
$319,177Paul J Martin · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer
$319,163Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R34 · FY2024 · CA
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
$319,158Matthew J Walter · Washington University · P50 · FY2020 · CA